Biote Corp

biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. It delivers a comprehensive, end-to-end platform that provides practitioners with medical education, training and certification, practice management software, and digital and point-of-care marketing support. The company is headquartered in Irving, TX.

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Biote Corp reports robust Q2 earnings, eyes men's health market

Biote Corp's Q2 2023 earnings call highlighted strong financial and strategic progress, marked by revenue growth, improved operating income, and a focus on expanding into new markets. While facing realignment challenges, the company remains confident in its outlook for continued growth and is dedicated to offering innovative wellness solutions.

Biote Corp reports revenue growth and plans nationwide wellness launch

Biote Corp (BTMD) demonstrated positive financial performance in Q3 2023 with revenue growth and improved EBITDA margin, driven by dietary supplements and procedures.
The company's strategic focus on expanding product offerings, engaging with key opinion leaders, and realigning sales territories positions them for future growth.
While facing challenges in procedure revenue growth and market dynamics, Biote Corp's initiatives to launch new offerings and target men's health present opportunities for expansion.

Biote Corp reports robust 2023 growth and targets strategic expansion

Biote Corp (BTMD) delivered strong financial performance in 2023 and sets ambitious targets for 2024, focusing on growth and efficiency.
The company's strategic initiatives, including new offerings and acquisitions, position it well for expansion and market leadership.
Challenges lie in optimizing operations and integration efforts, but Biote's commitment to innovation and growth bodes well for the future.

Biote Corp reports revenue growth and strategic acquisitions in Q1

Biote Corp (BTMD) delivered a solid performance in Q1 2024, marked by revenue growth, improved EBITDA, and strategic acquisitions.
While challenges like declining dietary supplement revenue and analyst inquiries exist, the company's strengths in product innovation and financial outlook bode well for future growth.
By capitalizing on opportunities in product development, geographic expansion, and market demand for wellness solutions, Biote Corp can further solidify its position in the industry.

Biote Corp reports solid Q3 earnings, eyes growth opportunities

Biote Corp (BTMD) delivered strong financial performance in Q3 2024, driven by revenue growth and operational efficiency.
While facing temporary challenges, the company remains focused on growth opportunities through market expansion and operational enhancements.
With a strategic focus on top-tier accounts, practitioner training, and technology integration, Biote is poised for continued success and profitability.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. It delivers a comprehensive, end-to-end platform that provides practitioners with medical education, training and certification, practice management software, and digital and point-of-care marketing support. The company was founded in 2012 and is headquartered in Irving, TX.

IRVING, Texas--(BUSINESS WIRE)--Biote Announces Participation in the Jefferies Healthcare Conference 2022

Biote Announces Participation in the Jefferies Healthcare Conference 2022

IRVING, Texas--(BUSINESS WIRE)---- $BTMD #hrt--4 in 10 working women in U.S. ages 50-65 say menopause symptoms have interfered with their work performance at least once a week.

National Women in the Workplace Survey: Women with Menopausal Symptoms Suffer in Silence in the Workplace

Haymaker Acquisition Corp 4

IRVING, Texas--(BUSINESS WIRE)--Biote Debuts as Publicly Traded Company Focused on Transforming Hormone Optimization Industry

Biote Debuts as Publicly Traded Company Focused on Transforming Hormone Optimization Industry

News for Biote Corp Stock (BTMD)